Recombinant Human EG-VEGF (PROK1)
如果您對該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: Recombinant Human EG-VEGF (PROK1)
產(chǎn)品型號: Z100145
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無相關(guān)文檔
簡單介紹
Recombinant Human EG-VEGF (PROK1)
Recombinant Human EG-VEGF (PROK1)
的詳細(xì)介紹
|
Print Version |
| Alternative Names |
EGVEGF, Mambakine, Prokineticin-1, PROK1
Recombinant Human Endocrine Gland Vascular Endothelial Growth Factor (PROK1) |
| Description |
This factor is identical to prokineticin-1 and is a member of the AVIT protein family. Expression of human EG-VEGF messenger RNA is restricted to the steroidogenic glands, ovary, testis, adrenal and placenta and is often complementary to the expression of VEGF. EG-VEGF has been identified as a mitogen specific for the endothelium of steroidogenic glands. EG-VEGF resembles VEGF in that it causes extensive angiogenesis and cyst formation when delivered in the ovary. EG-VEGF differs from VEGF in that it does not promote angiogenesis in the cornea or skeletal muscle. Two receptors have been characterized and are expressed in gastrointestinal organs, endocrine glands and other tissues. The G-protein-coupled receptors ZAQ and I5E both function as the EG-VEGF receptor. |
| Gene Symbol |
PROK1 |
| Gene ID |
84432 |
| Accession No. |
P58294 |
| Source |
E. coli |
| Appearance |
Lyophilized Powder |
| Molecular Weight |
10.0 kDa |
| Endotoxin Level |
<1.0 EU/μg of recombinant protein as determined by the LAL method. |
| Purity |
>95% as determined by SDS-PAGE |
| Bioactivity |
Not available. |
| Formulation |
Recombinant EG-VEGF was lyophilized from a 0.2 μm filtered PBS solution. |
| Reconstitution |
A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers. |
| Storage |
The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. |
| Usage |
For research use only. Not for diagnostic or therapeutic use. |
